Advisory: Alert incorrectly tagged to Curis Inc withdrawn
18/12/2025 19:00
An alert on Danish drugmaker Curasight A/S CURAS.TE announcing successful dosing of a patient in its brain cancer drug trial was inadvertently tagged to U.S.-based Curis Inc CRIS.O, an unrelated entity, and has been withdrawn. There will be no substitute STORY_NUMBER:nTUA1WR1VX STORY_DATE:18th December, 2025 STORY_TIME:06:46PM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Curis
See all newsCuris Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Curis Announces Pricing Of $5.6 Million Public Offering
Curis Inc expected to post a loss of $7.84 a share - Earnings Preview
Curis Inc expected to post a loss of $7.47 a share - Earnings Preview
Brief: Curis Doses First Five Patients In Takeaim Cll Study